Lai S, Molfino A, Coppola B, De Leo S, Tommasi V, Galani A, Migliaccio S, Greco E A, Gnerre Musto T, Muscaritoli M
Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3351-9.
Patients with chronic kidney disease (CKD) present a markedly increased cardiovascular (CV) morbidity and mortality since the early stages of the disease and a high prevalence of malnutrition, inflammation, and accelerated atherosclerosis. Personalized nutritional intervention, with of a low-protein diet (LPD), since the early stages of CKD should be able to achieve significant metabolic improvements. In our study we have verified the effects of a personalized dietary intervention in patients in the CKD stages 3/4 KDOQI on nutritional, metabolic and vascular indices.
We have evaluated renal function, lipid profile, mineral metabolism, inflammatory indices, and acid-base balance of 16 patients with CKD (stages 3/4 KDOQI). Assessment of nutritional status, body composition, bone mineral density and muscle mass, using body mass index (BMI), handgrip strength, bioelectrical impedance analysis (BIA), and dual energy X-ray absorptiometry (DEXA) was performed. Vascular indices and endothelial dysfunction such as carotid intima-media thickness (cIMT) and the brachial artery flow-mediated dilation (baFMD) were also analyzed.
After dietary interventions, we observed a significant increase in plasma bicarbonate (p = 0.004) and vitamin D levels (p = 0.03) and a concomitant significant reduction of phosphorus concentration (p = 0.001) and C-reactive protein (CRP) (p = 0.01).
Nutritional intervention potentially plays a major role in reducing the progression of CKD and systemic complications of predialysis patients. A low-protein diet (LPD) ensuring vegetable protein intake and a reduced amount of specific micronutrients should be recommended to stage 3/4 CKD patients in order to ameliorate metabolic profile, renal outcome, and reduce cardiovascular risk factors.
慢性肾脏病(CKD)患者自疾病早期起心血管(CV)发病率和死亡率就显著增加,且存在营养不良、炎症和动脉粥样硬化加速的高患病率。自CKD早期起采用低蛋白饮食(LPD)进行个性化营养干预应能实现显著的代谢改善。在我们的研究中,我们验证了CKD 3/4期KDOQI患者个性化饮食干预对营养、代谢和血管指标的影响。
我们评估了16例CKD(3/4期KDOQI)患者的肾功能、血脂谱、矿物质代谢、炎症指标和酸碱平衡。使用体重指数(BMI)、握力、生物电阻抗分析(BIA)和双能X线吸收法(DEXA)对营养状况、身体成分、骨密度和肌肉质量进行了评估。还分析了血管指标和内皮功能障碍,如颈动脉内膜中层厚度(cIMT)和肱动脉血流介导的扩张(baFMD)。
饮食干预后,我们观察到血浆碳酸氢盐(p = 0.004)和维生素D水平(p = 0.03)显著升高,同时磷浓度(p = 0.001)和C反应蛋白(CRP)(p = 0.01)显著降低。
营养干预可能在降低CKD进展和透析前患者的全身并发症方面发挥主要作用。应建议3/4期CKD患者采用确保植物蛋白摄入和特定微量营养素含量降低的低蛋白饮食(LPD),以改善代谢状况、肾脏结局并降低心血管危险因素。